BCAL Diagnostics Limited (AU:BDX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BCAL Diagnostics Limited announces the quotation of 3 million fully paid ordinary shares on the Australian Securities Exchange (ASX), following shareholder approval at the recent Annual General Meeting. This move marks a significant step for the company, potentially attracting investor interest and impacting stock market dynamics.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.